Enzymatic antioxidant balance and cognitive decline in aging - The EVA study

European Journal of Epidemiology

Volumn 19, Issue 2, 2004, Pages 133-138

  Berr, Claudine ^a,b   Richard, Marie Jeanne ^c   Gourlet, Véronique ^a   Garrel, Catherine ^c   Favier, Alain ^c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Montpellier 1 University   (France)

^c UNIV GRENOBLE ALPES   (France)

Author keywords

Cognition; Dementia; Glutathion peroxidase; Oxidative stress; Superoxide dismutase

Indexed keywords

ANTIOXIDANT; APOLIPOPROTEIN E; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE;

ADULT; AGE DISTRIBUTION; AGED; AGING; ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; EDUCATION; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RISK FACTOR;

AGE DISTRIBUTION; AGED; AGING; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; COGNITION DISORDERS; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FRANCE; GERIATRIC ASSESSMENT; GLUTATHIONE PEROXIDASE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SUPEROXIDE DISMUTASE;

EID: 1642271237     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:EJEP.0000017830.27594.e9     Document Type: Article

References (20)

1. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994; 344: 793-795.
2. Beal MF. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 1995; 38: 357-366.
3. Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev 1998; 78: 547-581.
4. Sinet PM. Metabolism of oxigen derivatives in Down's syndrome. Ann NY Acad Sci 1982; 396: 83-94.
5. De La Monte SM. Molecular abnormalities of the brain in Down syndrome: Relevance to Alzheimer's neurodegeneration. J Neural Transm Suppl 1999; 57: 1-19.
6. Markesbery WR. The role of oxidative stress in Alzheimer disease. Arch Neurol 1999; 56: 1449-1452.
7. Berr C, Richard MJ, Roussel AM, Bonithon-Kopp C, and the EVA study group. Systemic oxidative stress and cognitive performance in the population-based EVA study. Free Radical Biol Med 1998; 24: 1202-1208.
8. Berr C, Coudray C, Bonithon-kopp C, Roussel AM, Mainard F, Alperovitch A. Demographic and cardiovascular risk factors in relation to antioxidant status: The EVA Study. Int J Vitam Nutr Res 1998; 68: 26-35.
9. Bachman DL, Wolf AP, Linn RT, et al. Incidence of dementia and probable Alzheimer's disease in a general population: The Framingham Study. Neurology 1993; 43: 515-519.
10. Berr C, Dufouil C, Brousseau T, et al. Early effect of ApoE-epsilon 4 allele on cognitive results in a group of highly performing subjects: The EVA study. Neurosci Lett 1996; 218: 9-12.
11. Gunzler WA, Kremers H, Flohe L. An improved coupled test procedure for glutathione peroxidase in blood. Z Clin Chem Klin Biochem 1974; 12: 444-448.
12. Marklund SL, Marklund G. Involvement of superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974; 47: 469-474.
13. Berr C, Nicole A, Godin J, et al. Selenium and oxygen-metabolizing enzymes in elderly community residents: A pilot epidemiological study. J Am Geriatr Soc 1993; 41: 143-148.
14. Gale CR, Martyn CN, Cooper C. Cognitive impairment and mortality in a cohort of elderly people. Br Med J 1996; 312: 608-611.
15. Remacle J, Lambert D, Raes M, Pigeolet E, Michiels C, Toussaint O. Importance of various antioxidant enzymes for cell stability. Biochem J 1992; 286: 41-46.
16. Berr C, Balansard B, Arnaud J, Roussel AM, Alperovitch A. Cognitive decline is associated with systemic oxidative stress: The EVA study. Etude du Vieillissement Arteriel. J Am Geriatr Soc 2000; 48: 1285-1291.
17. Rayman MP. The importance of selenium to human health. Lancet 2000; 356: 233-241.
18. Ceballospicot I, Nicole A, Briand P, et al. Neuronal-specific expression of human copper-zinc superoxide dismutase gene in transgenic mice - animal model of gene dosage effects in down's syndrome. Brain Res 1991; 552: 198-214: 198-214.
19. Ceballospicot I, Nicole A, Clement M, Bourre JM, Sinet PM. Age-related changes in antioxidant enzymes and lipid peroxidation in brains of control and transgenic mice overexpressing copper-zinc superoxide dismutase. Mutation Res 1992; 275: 281-293.
20. Delanty N, Dichter MA. Antioxidant therapy in neurologic disease. Arch Neurol 2000; 57: 1265-1270.